FDA — authorised 13 February 2017
- Application: ANDA207952
- Marketing authorisation holder: TEVA PHARMS USA
- Local brand name: LOGILIA
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 PGL4001, progestin, drug free period in United States
FDA authorised PGL4001, progestin, drug free period on 13 February 2017
Marketing authorisation
Other Contraception / Women's Health approved in United States
Frequently asked questions
Is PGL4001, progestin, drug free period approved in United States?
Yes. FDA authorised it on 13 February 2017.
Who is the marketing authorisation holder for PGL4001, progestin, drug free period in United States?
TEVA PHARMS USA holds the US marketing authorisation.